Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yellen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scientific American|July 19, 2018
Capture That CarbonMadison Freeman, David Yellen
Scientific Reports|February 4, 2018
Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblastsBence György, Lilian Cruz, David Yellen, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scientific American|July 19, 2018
Capture That CarbonMadison Freeman, David Yellen
Scientific Reports|February 4, 2018
Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblastsBence György, Lilian Cruz, David Yellen, et al.
Science Advances|February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberinPike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Pageof 1